Life-extending drug for sufferers of lung disease caused by asbestos will finally be available on the NHS Pulmonary fibrosis sufferers will have chance to extend life by two years or more The condition...

The Australian government has pre-purchased 300,000 courses of an experimental antiviral oral drug called molnupiravir. Interim results announced by the company, US pharmaceutical Merck, show the drug...

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater...

Festival drug-related deaths are a growing public health concern. At present, there is limited evidence highlighting drug trends and harm-reduction practices among Irish festival attendees. One of the...

The development of drugs to treat cognitive problems in patients with mental illness may be a step closer after a team of researchers discovered that an existing drug—used to treat constipation—may...

Zeroing in on specific brain regions when studying drug and alcohol abuse simplifies research but may leave out important insights. In fact, the landscape of the entire brain reorganizes during withdrawal,...

An early phase trial of a drug currently used to treat lung fibrosis has shown it may also help patients who suffer from a common form of heart failure. Trialed by University of Manchester and Manchester...

An experimental drug can prevent intestinal damage caused by celiac disease, an early trial has found—raising hopes that it could become the first medication for the serious digestive disorder. With...

New research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) being held online (9-12 July) identifies drugs that could potentially be...

Weight-loss wonder drug that blitzes body fat may also reduce risk of heart attacks and strokes Rybelsus is a daily pill for obesity and diabetes, approved for use in UK last year It cuts calorie intake...